Drug
Wtx 124
Wtx 124: highest development phase Phase 1, developed by Werewolf Therapeutics, Inc.. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Werewolf Therapeutics, Inc.
Trials
| Drug | Phase | Indication |
|---|---|---|
| WTX-124 NCT05479812 | Phase 1 | Metastatic Solid Tumor |
Latest
No recent events.
Follow Wtx 124 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.